BioStock: Neola initiates usability study ahead of FDA approval
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

BioStock: Neola initiates usability study ahead of FDA approval

Lund-based Neola Medical continues to advance towards clinical studies with its lung monitoring system. The company is now starting a usability study – an important part of the process to be able to launch the product in the US. BioStock spoke to CEO Hanna Sjöström to find out more about the study.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/03/neola-initiates-usability-study-ahead-of-fda-approval/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Neola Medical

Läses av andra just nu

Om aktien Neola Medical

Senaste nytt